Biotech
Alexion Pharmaceuticals
Alexion Pharmaceuticals raises $40B Public at $42B valuation
121 Seaport Boulevard, Boston, MA 02210January 1, 20241 min read
Total Raised
$40B
Valuation
$42B
Latest Round
Public
Employees
3500+
Alexion Pharmaceuticals: Public Funding Round
Alexion Pharmaceuticals has successfully raised $40B in Public funding, reaching a valuation of $42B.
Company Overview
Biopharmaceutical company
Funding Details
The Public round was led by AstraZeneca.
Company Information
- Headquarters: 121 Seaport Boulevard, Boston, MA 02210
- Founded: 1992
- Employees: 3500+
- Category: Biotech
Investment
Alexion Pharmaceuticals plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- AstraZeneca: Verified investor in Public
Company Info
Headquarters
121 Seaport Boulevard, Boston, MA 02210
Founded
1992
Team Size
3500+
Last Round
$40B(Jan 2024)
Investors (1)
A
AstraZenecaLeadLead Investor
Verified investor in Public
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free